Vitreoretinal Technologies
Vitreoretinal Technologies an biopharmaceutical company of therapeutic compounds for the treatment of ophthalmic diseases.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Vitreoretinal Technologies Information
Geographic Data
Address:
City: Irvine
State: California
Zip:
Country: United States
Financial Info
Stage:
series a
Raised Last:
$12M
Raised Total:$12M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Vitreoretinal Technologies, Inc., an ophthalmic biopharmaceutical company, engages in the development and commercialization of therapeutic compounds for the treatment of ophthalmic diseases. The company focuses on vitreoretinal ophthalmic diseases and complications related to ophthalmic surgery. Its products include Vitreosolve, a drug used for the treatment of diabetic retinopathy, as well as to liquefy the vitreous gel prior to vitrectomy surgery; and Neurosolve, a compound used for glaucomatous optic nerve damage progression prevention, dry age related macular degeneration progression, and retinitis pigmentosa treatment.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2007 | Series A | 1 | $12M |
DeNovo Ventures DeNovo Ventures |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
